Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin F Creeden

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Vaccines|October 6, 2020
Resident Memory T Cells and Their Effect on CancerDaniel J Craig, Justin F Creeden, Katelyn R Einloth, et al.
Physiological Genomics|August 19, 2020
Oxytocin's anti-inflammatory and proimmune functions in COVID-19: a transcriptomic signature-based approachAli S Imami, Sinead M O'Donovan, Justin F Creeden, et al.
International Journal of Molecular Sciences|November 25, 2020
Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer DesmoplasiaJustin F Creeden, Khaled Alganem, Ali S Imami, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 2, 2024
Smart exosomes enhance PDAC targeted therapyJustin F Creeden, Jonathan Sevier, Jian-Ting Zhang, et al.
Cancer Letters|August 24, 2020
Repurposing metformin, simvastatin and digoxin as a combination for targeted therapy for pancreatic ductal adenocarcinomaShi-He Liu, Juehua Yu, Justin F Creeden, et al.
Future Oncology (London, England)|November 1, 2019
<i>Bifidobacterium spp</i>: the promising Trojan Horse in the era of precision oncologyNealie Ngo, Khalil Choucair, Justin F Creeden, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|May 22, 2023
Loss of hepatic PPARα in mice causes hypertension and cardiovascular diseaseOlufunto O Badmus, Zachary A Kipp, Evelyn A Bates, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 1, 2020
Signature-based approaches for informed drug repurposing: targeting CNS disordersRammohan Shukla, Nicholas D Henkel, Khaled Alganem, et al.
Current Opinion in Pharmacology|December 30, 2021
The active kinome: The modern view of how active protein kinase networks fit in biological researchKhaled Alganem, Abdul-Rizaq Hamoud, Justin F Creeden, et al.
Biomolecules|February 25, 2023
Suppressing Hepatic UGT1A1 Increases Plasma Bilirubin, Lowers Plasma Urobilin, Reorganizes Kinase Signaling Pathways and Lipid Species and Improves Fatty Liver DiseaseEvelyn A Bates, Zachary A Kipp, Genesee J Martinez, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Vaccines|October 6, 2020
Resident Memory T Cells and Their Effect on CancerDaniel J Craig, Justin F Creeden, Katelyn R Einloth, et al.
Physiological Genomics|August 19, 2020
Oxytocin's anti-inflammatory and proimmune functions in COVID-19: a transcriptomic signature-based approachAli S Imami, Sinead M O'Donovan, Justin F Creeden, et al.
International Journal of Molecular Sciences|November 25, 2020
Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer DesmoplasiaJustin F Creeden, Khaled Alganem, Ali S Imami, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 2, 2024
Smart exosomes enhance PDAC targeted therapyJustin F Creeden, Jonathan Sevier, Jian-Ting Zhang, et al.
Cancer Letters|August 24, 2020
Repurposing metformin, simvastatin and digoxin as a combination for targeted therapy for pancreatic ductal adenocarcinomaShi-He Liu, Juehua Yu, Justin F Creeden, et al.
Future Oncology (London, England)|November 1, 2019
<i>Bifidobacterium spp</i>: the promising Trojan Horse in the era of precision oncologyNealie Ngo, Khalil Choucair, Justin F Creeden, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|May 22, 2023
Loss of hepatic PPARα in mice causes hypertension and cardiovascular diseaseOlufunto O Badmus, Zachary A Kipp, Evelyn A Bates, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 1, 2020
Signature-based approaches for informed drug repurposing: targeting CNS disordersRammohan Shukla, Nicholas D Henkel, Khaled Alganem, et al.
Current Opinion in Pharmacology|December 30, 2021
The active kinome: The modern view of how active protein kinase networks fit in biological researchKhaled Alganem, Abdul-Rizaq Hamoud, Justin F Creeden, et al.
Biomolecules|February 25, 2023
Suppressing Hepatic UGT1A1 Increases Plasma Bilirubin, Lowers Plasma Urobilin, Reorganizes Kinase Signaling Pathways and Lipid Species and Improves Fatty Liver DiseaseEvelyn A Bates, Zachary A Kipp, Genesee J Martinez, et al.
Pageof 3